International

Lung Cancer Summit

Virtual Live Conference

from October 13: University Hospital Geneva

all lectures now available on demand!

 

REGISTRATION STILL OPEN

 

 

 

Register HereGo To Meeting Now
[ba_animated_text animated_text=”%91{%22value%22:%22Our Chairs%22,%22checked%22:0,%22dragID%22:-1},{%22value%22:%22Our Hosts Invite You to Join%22,%22checked%22:0,%22dragID%22:0}%93″ animation_speed=”50ms” start_delay=”500ms” use_loop=”off” cursor_text=”.” text_alignment=”center” _builder_version=”4.9.2″ _module_preset=”default” animated_text_color=”#2B4361″ animated_font_size=”36px” animated_letter_spacing=”2px” module_alignment=”center” animated_text_shadow_style=”preset1″ animated_text_shadow_color=”#C9C9C9″ global_colors_info=”{}”][/ba_animated_text]
Alfredo Addeo, MD
Alfredo Addeo, MD

Alfredo Addeo, MD, is a Consultant Medical Oncologist at the University Hospital of Geneva, Switzerland. He is the author of numerous national and international peer-reviewed publications in renowned scientific journals, including first- and last-author publications in the Journal of Clinical Oncology, Annals of Oncology and Lancet Oncology. He has acted as a reviewer for several international scientific journals, including Journal of Thoracic Oncology and JAMA Oncology, and is an associate editor for Frontiers in Thoracic Oncology and guest editor for Precision Cancer Medicine. Dr. Addeo is an active ESMO member and a member of the EORTC lung group. He actively participates in ETOP (European Thoracic Oncology Platform) and SAKK (the Swiss Group for Clinical Cancer Research) and is a researcher and co-investigator of several national and international studies.

Solange Peters, MD-PhD
Solange Peters, MD-PhD

Solange Peters, MD-PhD, is Professor and chair of Medical Oncology as well as the Thoracic Malignancies programme in the department of oncology at the University Hospital of Lausanne, Switzerland. She has authored numerous peer-reviewed manuscripts and book chapters, and serves as deputy editor of the Journal of Thoracic Oncology, and on the editorial board of several other oncology journals. Professor Peters is active in the educational programs of the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC), notably working as the current editor of the ESMO lung cancer clinical practice guidelines. She is the Chair of ESMO Women for Oncology Committee, and she is the youngest ESMO President ever, for a mandate in 2020-2021. She was also a member of the IASLC board of directors, and acts as vice president of the Swiss Group for Clinical Cancer Research lung group. She received both her doctorate in medicine and PhD from the University Hospital of Lausanne, Switzerland. After completing her clinical education in medical oncology and molecular biology in Switzerland and Italy, Professor Peters has specialized in thoracic tumors, lung cancer, and pleural tumors.

[ba_animated_text animated_text=”%91{%22value%22:%22Our Experts%22,%22checked%22:0,%22dragID%22:-1},{%22value%22:%22Our Speakers%22,%22checked%22:0,%22dragID%22:0},{%22value%22:%22Our Faculty%22,%22checked%22:0,%22dragID%22:1}%93″ cursor_text=”.” text_alignment=”center” _builder_version=”4.9.2″ _module_preset=”default” animated_text_color=”#FFFFFF” animated_font_size=”36px” animated_letter_spacing=”2px” module_alignment=”center” animated_text_shadow_style=”preset3″ animated_text_shadow_color=”#FFFFFF” global_colors_info=”{}”][/ba_animated_text][ba_image_carousel animation_speed=”1200ms” autoplay_speed=”3200ms” use_nav=”off” use_pagi=”on” slide_count=”5″ slide_spacing=”0px” use_both_side_spacing=”off” is_swipe=”off” pagi_bg=”#C9C9C9″ pagi_pos_y=”-150%” pagi_bg_active=”#2B4361″ slide_count_tablet=”” slide_count_phone=”2″ slide_count_last_edited=”on|phone” slide_to_scroll_phone=”1″ slide_to_scroll_last_edited=”off|phone” _builder_version=”4.9.2″ _module_preset=”default” custom_margin=”-2%||||false|false” custom_padding=”0px||||false|false” global_colors_info=”{}”][ba_image_carousel_child photo=”https://www.lungcancersummit.org/wp-content/uploads/2021/08/Banna-Giuseppe-RGB-320×320-1.jpg” photo_alt=”Giuseppe Banna” title=”Giuseppe Banna” sub_title=”Candiolo Cancer Institute Turin, Italy” _builder_version=”4.9.2″ _module_preset=”default” title_text_color=”#FFFFFF” title_font_size=”24px” subtitle_text_color=”#1B1A2A” subtitle_font_size=”20px” global_colors_info=”{}”][/ba_image_carousel_child][ba_image_carousel_child photo=”https://www.lungcancersummit.org/wp-content/uploads/2021/08/Borghaei-Hossein-320×320-1.jpg” photo_alt=”Hossein Borghaei” title=”Hossein Borghaei” sub_title=”Fox Chase Cancer Center Philadelphia, USA” _builder_version=”4.9.2″ _module_preset=”default” title_text_color=”#FFFFFF” title_font_size=”24px” subtitle_text_color=”#1B1A2A” subtitle_font_size=”20px” global_colors_info=”{}”][/ba_image_carousel_child][ba_image_carousel_child photo=”https://www.lungcancersummit.org/wp-content/uploads/2021/08/Calles-Antonio-320.jpg” photo_alt=”Antonio Calles” title=”Antonio Calles” sub_title=”Hospital General Univ. Gregorio Marañón, Spain” _builder_version=”4.9.2″ _module_preset=”default” title_text_color=”#FFFFFF” title_font_size=”24px” subtitle_text_color=”#1B1A2A” subtitle_font_size=”20px” global_colors_info=”{}”][/ba_image_carousel_child][ba_image_carousel_child photo=”https://www.lungcancersummit.org/wp-content/uploads/2021/08/Curioni-Alessandra-320×320-1.jpg” photo_alt=”Alessandra Curioni” title=”Alessandra Curioni” sub_title=”University Hospital Zurich, Switzerland” _builder_version=”4.9.2″ _module_preset=”default” title_text_color=”#FFFFFF” title_font_size=”24px” subtitle_text_color=”#1B1A2A” subtitle_font_size=”20px” global_colors_info=”{}”][/ba_image_carousel_child][ba_image_carousel_child photo=”https://www.lungcancersummit.org/wp-content/uploads/2021/08/Finn-Stephen-320×320-1.jpg” photo_alt=”Stephen Finn” title=”Stephen Finn” sub_title=”St. James Hospital, Trinity College Dublin, Ireland” _builder_version=”4.9.2″ _module_preset=”default” title_text_color=”#FFFFFF” title_font_size=”24px” subtitle_text_color=”#1B1A2A” subtitle_font_size=”20px” global_colors_info=”{}”][/ba_image_carousel_child][/ba_image_carousel][ba_image_carousel animation_speed=”1200ms” autoplay_speed=”3200ms” use_nav=”off” use_pagi=”on” slide_count=”5″ slide_spacing=”0px” use_both_side_spacing=”off” is_swipe=”off” pagi_bg=”#C9C9C9″ pagi_pos_y=”-150%” pagi_bg_active=”#2B4361″ slide_count_tablet=”” slide_count_phone=”2″ slide_count_last_edited=”on|phone” slide_to_scroll_tablet=”” slide_to_scroll_phone=”1″ slide_to_scroll_last_edited=”on|desktop” _builder_version=”4.9.2″ _module_preset=”default” custom_margin=”-5%||||false|false” custom_padding=”0px||||false|false” global_colors_info=”{}”][ba_image_carousel_child photo=”https://www.lungcancersummit.org/wp-content/uploads/2021/08/Friedlaender-Alex-320.jpg” photo_alt=”Alex Friedlaender” title=”Alex Friedlaender” sub_title=”Clinique Générale-Beaulieu Univ. Hosp. Geneva, Switzerland” _builder_version=”4.9.2″ _module_preset=”default” title_text_color=”#FFFFFF” title_font_size=”24px” subtitle_text_color=”#1B1A2A” subtitle_font_size=”20px” global_colors_info=”{}”][/ba_image_carousel_child][ba_image_carousel_child photo=”https://www.lungcancersummit.org/wp-content/uploads/2021/08/Lovly-Christine-320×320-1.jpg” photo_alt=”Christine Lovly” title=”Christine Lovly” sub_title=”Vanderbilt Medical Center, Nashville, USA” _builder_version=”4.9.2″ _module_preset=”default” title_text_color=”#FFFFFF” title_font_size=”24px” subtitle_text_color=”#1B1A2A” subtitle_font_size=”20px” global_colors_info=”{}”][/ba_image_carousel_child][ba_image_carousel_child photo=”https://www.lungcancersummit.org/wp-content/uploads/2021/08/Naidoo-Jarushka-320.jpg” photo_alt=”Jarushka Naidoo” title=”Jarushka Naidoo” sub_title=”Beaumont Hospital Dublin, Ireland” _builder_version=”4.9.2″ _module_preset=”default” title_text_color=”#FFFFFF” title_font_size=”24px” subtitle_text_color=”#1B1A2A” subtitle_font_size=”20px” global_colors_info=”{}”][/ba_image_carousel_child][ba_image_carousel_child photo=”https://www.lungcancersummit.org/wp-content/uploads/2021/08/Noronha-Vanita-320×320-1.jpg” photo_alt=”Vanita Noronha” title=”Vanita Noronha” sub_title=”Tata Memorial Hospital, Mumbai, India” _builder_version=”4.9.2″ _module_preset=”default” title_text_color=”#FFFFFF” title_font_size=”24px” subtitle_text_color=”#1B1A2A” subtitle_font_size=”20px” global_colors_info=”{}”][/ba_image_carousel_child][ba_image_carousel_child photo=”https://www.lungcancersummit.org/wp-content/uploads/2021/08/VanEeden-Ronwyn-320×320-1.jpg” photo_alt=”Ronwyn van Eeden” title=”Ronwyn van Eeden” sub_title=”Medical Oncology Centre Rosebank, South Africa” _builder_version=”4.9.2″ _module_preset=”default” title_text_color=”#FFFFFF” title_font_size=”24px” subtitle_text_color=”#1B1A2A” subtitle_font_size=”20px” global_colors_info=”{}”][/ba_image_carousel_child][/ba_image_carousel]
[ba_animated_text animated_text=”%91{%22value%22:%22Our Agenda%22,%22checked%22:0,%22dragID%22:-1},{%22value%22:%22Our Schedule%22,%22checked%22:0,%22dragID%22:0},{%22value%22:%22Our CME-Certified Program%22,%22checked%22:0,%22dragID%22:1}%93″ animation_speed=”80ms” use_loop=”off” cursor_text=”.” text_alignment=”center” _builder_version=”4.9.2″ _module_preset=”default” animated_text_color=”#FFFFFF” animated_font_size=”36px” animated_letter_spacing=”2px” module_alignment=”center” animated_text_shadow_style=”preset3″ animated_text_shadow_color=”#FFFFFF” global_colors_info=”{}”][/ba_animated_text]

Following the great success of the virtual International Lung Cancer Summit (ILCS), we look forward to welcoming you to the 3rd edition of this interactive hybrid meeting. Similar to recent years, the ILCS will showcase latest discoveries and advances performed towards the treatment of lung cancer. The conference will leverage digital channels to provide with an exceptional outreach and opportunity for delegates from Medical Offices, Universities and Institutes to interact with world-class Medical Oncologists and Industry Professionals working in the field of lung cancer treatment and research.
The ILCS constitutes an ideal platform to share knowledge and seamless treatment procedures with our local and international speakers from the USA, Spain, Ireland, Italy, South Africa, India and Switzerland.

This meeting is accredited and CME-certified by the Swiss Society of Medical Oncology with 5 credit points. Join us and get your certificate of attendance in the virtual meeting room.

5 SGMO CME Credits

SSMO • SSOM • SGMO

Wednesday, 13 October 2021 – All Talks Now Available On Demand!

Indicated Time Zone: Central European Summer Time (CEST)

10.00

Welcome by Chairs

Solange Peters & Alfredo Addeo (Switzerland)

10.05

Latest treatment updates for frontline non-oncogene addicted NSCLC

Hossein Borghaei (USA)

10.30

How do we tailor treatments for later lines of therapy in the IO era

Giuseppe Banna (United Kingdom)

11.00

Integrating immunotherapy into localized NSCLC

Antonio Calles (Spain)

11.20

Open discussion & coffee break

11.45

Current standard of care and challenges in Small Cell Lung Cancer

Alessandra Curioni (Switzerland)

12.10

The art of balance: approaching immune-related adverse events in thoracic oncology

Jarushka Naidoo (Ireland)

13.45

State of the art in biopsy testing: the paths we set for lung cancer treatment

Stephen Finn (Ireland)

14.10

The latest on targeting EGFR+ Non-Small Cell Lung Cancer

Vanita Noronha (India)

14.40

ALK+ and ROS1: which TKI is suitable for which patient?

Alex Friedlaender (Switzerland)

15.00

Open discussion & coffee break

15.20

KRAS and HER2: Expanding the horizons for the treatment of lung cancer

Christine Lovly (USA)

15.45

RET, MET, NTRK… a new era for targeted therapies in all mutations?

Ronwyn van Eeden (South Africa)

16.10

Wrap up & Final Questions

Solange Peters & Alfredo Addeo (Switzerland)
[ba_animated_text animated_text=”%91{%22value%22:%22Our Sponsors%22,%22checked%22:0,%22dragID%22:-1},{%22value%22:%22Our Partners%22,%22checked%22:0,%22dragID%22:0}%93″ animation_speed=”50ms” cursor_text=”.” text_alignment=”center” _builder_version=”4.9.2″ _module_preset=”default” animated_text_color=”#2B4361″ animated_font_size=”36px” animated_letter_spacing=”2px” module_alignment=”center” animated_text_shadow_style=”preset1″ animated_text_shadow_color=”#C9C9C9″ global_colors_info=”{}”][/ba_animated_text]

The International Lung Cancer Summit 2021 was made possible with the kind support by our partners with no influence on the content:

MSD Logo
Eli Lilly Logo
AstraZeneca Logo
Amgen Logo
Novartis Logo
Bayer Logo
Janssen Logo
Pfizer Logo
Roche Logo
Takeda Logo
BMS Logo
Frontiers Logo
Sanofi Genzyme Logo
Merck Logo

Follow Us For The Latest News on Twitter & LinkedIn

Are there molecular factors which influence immunotherapy decision making in the frontline space for #LungCancer? 🤔

A great question from @PatelOncology. Hear @DrJNaidoo thoughts on this & why solid data is important ➡️ http://lungcancersummit.org

#LungCancerAwarenessMonth 🫁

Image for the Tweet beginning: Are there molecular factors which

An entire gallery of this year's #LungSummit is now available!

Browse photos and catch any talk by our thoracic experts, anytime and anywhere.

➡️ http://lungcancersummit.org

#LungCancer continues to be a leading cause of death worldwide 🌎

Learn more about the disease, its risk factors, and more with us over this #LungCancerAwarenessMonth 🫁

Image for the Tweet beginning: #LungCancer continues to be a

Thank you for 2️⃣0️⃣0️⃣0️⃣ plus followers! 

The #LungSummit unites thoracic experts to learn more and advance treatments and standard of care for #LungCancer 🫁

Let's bridge the gap in thoracic oncology together.

http://lungcancersummit.org

Image for the Tweet beginning: Thank you for 2️⃣0️⃣0️⃣0️⃣ plus

#LungSummit22 was more global than ever, with over 1000 viewers from over 75 countries 🌎

Thanks to our hosts, @Alfdoc2 & @peters_solange, alongside our thoracic experts and to everyone who joined us, whether in Lausanne or online!

Image for the Tweet beginning: #LungSummit22 was more global than

Did you catch Sabina Berezowska's (@CHUVLausanne ) talk on #biomarkers and targets used in #pathology for #LungCancer at the last #LungSummit? 🫁

Let us know your thoughts on the question below 🤔

What would you prefer for your patients in #LungCancer biomarker testing?

Load More...